Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. ANI Pharmaceuticals (ANIP) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
ANI Pharmaceuticals is a member of the Medical sector. This group includes 947 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. ANI Pharmaceuticals is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for ANIP's full-year earnings has moved 5.5% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that ANIP has returned about 45.4% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of 6.4% on a year-to-date basis. As we can see, ANI Pharmaceuticals is performing better than its sector in the calendar year.
Another Medical stock, which has outperformed the sector so far this year, is Aveanna Healthcare (AVAH). The stock has returned 97.4% year-to-date.
The consensus estimate for Aveanna Healthcare's current year EPS has increased 40.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, ANI Pharmaceuticals belongs to the Medical - Biomedical and Genetics industry, a group that includes 465 individual companies and currently sits at #87 in the Zacks Industry Rank. On average, this group has gained an average of 18.4% so far this year, meaning that ANIP is performing better in terms of year-to-date returns.
On the other hand, Aveanna Healthcare belongs to the Medical - Outpatient and Home Healthcare industry. This 15-stock industry is currently ranked #32. The industry has moved +8.3% year to date.
Investors with an interest in Medical stocks should continue to track ANI Pharmaceuticals and Aveanna Healthcare. These stocks will be looking to continue their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ANI Pharmaceuticals, Inc. (ANIP): Free Stock Analysis Report Aveanna Healthcare Holdings Inc. (AVAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
